PLYX · Polaryx Therapeutics, Inc.
$2.11
+0.02 (+0.96%)
At close · Aug 27
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, along with the conditions described above, raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the date these financial statements were available to be issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$104.18M
Shares
49.85M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
Key facts
CIK
2075320
CUSIP
73110F100
13F (30d)
12 filings
12 filers
Visit website
Investor relations